Kazia Therapeutics Ltd (KZIA) stock
KZIANasdaqPharmaceutical PreparationsFiscal year ends June 30
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Jun 30, 2025Last filing: 20-F on Nov 17, 2026Score 1/30
$5.49+0.18 (+3.39%)
Close on Nov 18, 2026Market cap $8.89MP/E –Yield –
Kazia Therapeutics enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Kazia Therapeutics's enterprise value was -$39.54M on Nov 11, 2026, against $8.97M a year earlier. Over the last 5 years it ranged from -$40.13M to $79.05M, with a median of $5.29M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | -$39.54M | -904.2% |
| 2025 | Dec 31, 2025 | $4.92M | +21.9% |
| 2024 | Dec 31, 2024 | $4.03M | -29.8% |
| 2023 | Dec 29, 2023 | $5.75M | +32.9% |
| 2022 | Dec 30, 2022 | $4.32M | -94.5% |
| 2021 | Dec 31, 2021 | $79.05M | +40.3% |
| 2020 | Dec 31, 2020 | $56.36M | +166.7% |
| 2019 | Dec 31, 2019 | $21.14M | +179.6% |
| 2018 | Dec 31, 2018 | $7.56M | -94.5% |
| 2017 | Dec 29, 2017 | $137.47M | -39.5% |
| 2016 | Dec 30, 2016 | $227.14M | – |
See a number that looks wrong?